Better than RECIST and faster than iRECIST: defining the Immunotherapy Progression Decision score to better manage progressive tumors on immunotherapy - Inria - Institut national de recherche en sciences et technologies du numérique Access content directly
Poster Communications Year : 2022

Better than RECIST and faster than iRECIST: defining the Immunotherapy Progression Decision score to better manage progressive tumors on immunotherapy

Hugues Talbot
Fichier principal
Vignette du fichier
Poster_ESMO (4).pdf (249.33 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03780911 , version 1 (19-09-2022)

Identifiers

  • HAL Id : hal-03780911 , version 1

Cite

Younes Belkouchi, Hugues Talbot, Nathalie Lassau, Littisha Lawrance, Siham Farhane, et al.. Better than RECIST and faster than iRECIST: defining the Immunotherapy Progression Decision score to better manage progressive tumors on immunotherapy. ESMO 2022, Sep 2022, Paris, France. . ⟨hal-03780911⟩
107 View
148 Download

Share

Gmail Facebook X LinkedIn More